港交所(00388.HK)任命周健男為內地業務發展主管
港交所(00388.HK)宣布兩項內地業務高層任命,周健男將於7月18日加入港交所,擔任內地業務發展主管,並成為管理委員會成員,將領導港交所與內地主要監管機構和合作夥伴的合作。
而現任內地業務發展主管毛志榮,將轉任新設立的中國大宗商品及大灣區戰略顧問。二人均將向聯席營運總監陳翊庭匯報。
集團行政總裁歐冠昇表示,在過去市場發展的關鍵時期,毛志榮為港交所內地發展戰略做出的重大貢獻,相信轉任新職位後將繼續協助交易所發展大灣區戰略和大宗商品業務,同時歡迎周健男的加入,預期將進一步增強港交所在中國內地業務方面的專業經驗和佈局。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.